-
1
-
-
0000601871
-
Declaration of Helsinki
-
World Medical Association. Declaration of Helsinki. JAMA 2013;310:2191-4.
-
(2013)
JAMA
, vol.310
, pp. 2191-4
-
-
-
3
-
-
84861998609
-
Should preclinical studies be registered?
-
Kimmelman J, Anderson JA. Should preclinical studies be registered? Nat Biotechnol 2012;30:488-9.
-
(2012)
Nat Biotechnol
, vol.30
, pp. 488-9
-
-
Kimmelman, J.1
Anderson, J.A.2
-
4
-
-
0006266243
-
Guidance for Industry: Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-derived Products
-
In: Services USDoH, ed.
-
Guidance for Industry: Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-derived Products. In: Services USDoH, ed., 1995.
-
(1995)
-
-
-
5
-
-
84898407393
-
Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products
-
In: Services USDoHH, ed.
-
Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products. In: Services USDoHH, ed., 2013.
-
(2013)
-
-
-
6
-
-
84905438349
-
Guidance for Industry: Product Development Under the Animal Rule
-
U.S. Department of Health and Human Services FaDA, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Guidance for Industry: Product Development Under the Animal Rule 2014.
-
(2014)
-
-
-
7
-
-
0027524863
-
Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents
-
Ratain MJ, Mick R, Schilsky RL, et al. Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents. J Natl Cancer Inst 1993;85:1637-43.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1637-43
-
-
Ratain, M.J.1
Mick, R.2
Schilsky, R.L.3
-
8
-
-
84881240391
-
Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments
-
Henderson VC, Kimmelman J, Fergusson D, et al. Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Med 2013;10:e1001489.
-
(2013)
PLoS Med
, vol.10
-
-
Henderson, V.C.1
Kimmelman, J.2
Fergusson, D.3
-
9
-
-
84878898016
-
The laboratory rat: relating its age with human's
-
Sengupta P. The laboratory rat: relating its age with human's. Int J Prev Med 2013;4:624-30.
-
(2013)
Int J Prev Med
, vol.4
, pp. 624-30
-
-
Sengupta, P.1
-
10
-
-
79953704023
-
Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty
-
Kimmelman J, London AJ. Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty. PLoS Med 2011;8:e1001010.
-
(2011)
PLoS Med
, vol.8
-
-
Kimmelman, J.1
London, A.J.2
-
11
-
-
84872166025
-
Building an ethical foundation for first-in-human nanotrials
-
Dresser R. Building an ethical foundation for first-in-human nanotrials. J Law Med Ethics 2012;40:802-8.
-
(2012)
J Law Med Ethics
, vol.40
, pp. 802-8
-
-
Dresser, R.1
-
14
-
-
77952844165
-
Extending clinical equipoise to phase 1 trials involving patients: unresolved problems
-
Anderson JA, Kimmelman J. Extending clinical equipoise to phase 1 trials involving patients: unresolved problems. Kennedy Inst Ethics J 2010;20:75-98.
-
(2010)
Kennedy Inst Ethics J
, vol.20
, pp. 75-98
-
-
Anderson, J.A.1
Kimmelman, J.2
-
16
-
-
84953257168
-
-
For Authors Manuscript Formatting Guide. Secondary For Authors Manuscript Formatting Guide
-
For Authors Manuscript Formatting Guide. Secondary For Authors Manuscript Formatting Guide. http://www.nature.com/nature/authors/gta/-a5.9
-
-
-
-
17
-
-
0742266629
-
"Special scrutiny": a targeted form of research protocol review
-
Levine C, Faden R, Grady C, et al. "Special scrutiny": a targeted form of research protocol review. Ann Intern Med 2004;140:220-3.
-
(2004)
Ann Intern Med
, vol.140
, pp. 220-3
-
-
Levine, C.1
Faden, R.2
Grady, C.3
-
18
-
-
77950572352
-
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy
-
Sena ES, van der Worp HB, Bath PM, et al. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 2010;8:e1000344.
-
(2010)
PLoS Biol
, vol.8
-
-
Sena, E.S.1
van der Worp, H.B.2
Bath, P.M.3
-
19
-
-
41249090758
-
Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach
-
Crossley NA, Sena E, Goehler J, et al. Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke 2008;39:929-34.
-
(2008)
Stroke
, vol.39
, pp. 929-34
-
-
Crossley, N.A.1
Sena, E.2
Goehler, J.3
-
20
-
-
84860445985
-
Research ethics. Rethinking research ethics: the case of postmarketing trials
-
London AJ, Kimmelman J, Carlisle B. Research ethics. Rethinking research ethics: the case of postmarketing trials. Science 2012;336:544-5.
-
(2012)
Science
, vol.336
, pp. 544-5
-
-
London, A.J.1
Kimmelman, J.2
Carlisle, B.3
|